Baird Medical appoints Mark Saxton as CEO of US subsidiary.
ByAinvest
Wednesday, Dec 3, 2025 8:37 am ET1min read
BDMD--
• Baird Medical appoints Mark Saxton as CEO of US subsidiary • Saxton has 25+ years of medical device commercial leadership experience • Experience in intravascular RF ablation technologies • Saxton to lead US sales, marketing, and market development • Baird Medical accelerates US market entry • Haimei Wu, Chairwoman, welcomes Saxton to the team • Saxton's proven track record in taking novel technologies to market leadership • Saxton to create significant shareholder value for Baird Medical
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet